Below is a list of the top pharmaceutical companies worldwide based on prescription drug sales in 2017. Pharm Exec, which partnered with market intelligence firm Evaluate to collect the data, generated the list.
Here are the 20 top pharma companies by prescription drug sales:
1. Pfizer — $45.35 billion
2. Novartis — $41.88 billion
3. Roche — $41.73 billion
4. Merck — $35.27 billion
5. Johnson & Johnson — $34.4 billion
6. Sanofi — $34.08 billion
7. GlaxoSmithKline — $28.67 billion
8. AbbVie — $27.75 billion
9. Gilead Sciences — $25.66 billion
10. Amgen —$21.8 billion
11. AstraZeneca — $19.78 billion
12. Bristol-Myers Squibb — $19.26 billion
13. Eli Lilly — $18.52 billion
14. Teva Pharmaceutical Industries — $18.26 billion
15. Bayer — $17.54 billion
16. Novo Nordisk — $16.97 billion
17. Allergan — $14.91 billion
18. Shire — $14.26 billion
19. Boehringer Ingelheim — $14.26 billion
20. Takeda — $13.58 billion
Read the full list here.
More articles on pharmacy:
Allergan sues Pfizer over costs related to opioid lawsuits
Teva’s revenue drops 18% in Q2
Who knew? There’s a trophy for ‘most hated’ pharma chief: 10 notes
